Central Laboratories White Papers & Articles

31. Biotech Landscape Continues To Shift 9/18/2025

    Global shifts are adding new layers of challenge and opportunity for the biotech sector, as companies navigate a period of unprecedented complexity.

32. The Strategic Role Of Biostatistics In Clinical Trials 9/17/2025

    Early biostatistical input strengthens trial design, reduces risk, and ensures meaningful outcomes while strategic involvement drives smarter decisions. Learn why timing and collaboration matter.

33. Everest Group Life Sciences eCOA Peak Matrix Assessment 2025 9/16/2025

    Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.

34. How AI Is Reshaping The Future Of Clinical Research 9/15/2025

    Artificial intelligence (AI) is rapidly transforming clinical research, with innovative applications in key areas such as real-world evidence generation, regulatory submissions, and biomarker discovery.

35. The Data Dilemma: Balancing Innovation With Trust In Healthcare 9/15/2025

    Despite frequent data breaches, patients remain willing to share their health data with trusted healthcare providers that prioritize transparency and ethical stewardship.

36. From Bottlenecks To Breakthroughs: How AI Is Transforming Translation Timelines 9/12/2025

    Take a deeper look at AI-enabled translations and uncover how they are able to drive a remarkable 43% reduction in overall translation timelines.

37. AI-Powered Strategy Is Redefining Patient Recruitment Performance 9/9/2025

    This AI-powered platform is helping CROs and sponsors tackle the unsolved challenge they've faced for decades: clinical trials that launch late, recruit slowly, and miss enrollment targets.

38. Tackling Special Characters With SAS And R 9/3/2025

    Protect the integrity of your research by proactively detecting and removing hidden characters to ensure accurate, reliable, and compliant study results.

39. Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO 9/2/2025

    In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.

40. Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows 9/2/2025

    Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.